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Comparing Phylogeny and the Predicted Pathogenicity
of Protein Variations Reveals Equal Purifying Selection
across the Global Human mtDNA Diversity
Luı´sa Pereira,1,2 Pedro Soares,1 Predrag Radivojac,3 Biao Li,3 and David C. Samuels4,*
We used detailed phylogenetic trees for human mtDNA, combined with pathogenicity predictions for each amino acid change, to eval-
uate selection on mtDNA-encoded protein variants. Protein variants with high pathogenicity scores were significantly rarer in the older
branches of the tree. Variants that have formed and survived multiple times in the human phylogenetics tree had significantly lower
pathogenicity scores than those that only appear once in the tree. We compared the distribution of pathogenicity scores observed on
the human phylogenetic tree to the distribution of all possible protein variations to define a measure of the effect of selection on these
protein variations. The measured effect of selection increased exponentially with increasing pathogenicity score. We found no measur-
able difference in thismeasure of purifying selection inmtDNA across the global population, represented by themacrohaplogroups L,M,
and N. We provide a list of all possible single amino acid variations for the human mtDNA-encoded proteins with their predicted path-
ogenicity scores and our measured selection effect as a tool for assessing novel protein variations that are often reported in patients with
mitochondrial disease of unknown origin or for assessing somatic mutations acquired through aging or detected in tumors.Introduction
mtDNA population studies1 have shown how human
migrations and genetic drift were responsible for the
current distribution of maternal lineages across the world;
the oldest lineages (designated by L) are observed in Africa,
whereas all non-African clades can be subdivided into two
groups (M and N) derived from the African haplogroup L3.
Broadly, L (except for the M and N subclades of L3) is only
observed in populations of African ancestry,2 whereas M is
most frequent in South and East Asia3–5 and N has a vast
geographic distribution but is the only macrohaplogroup
in West Eurasia and Southwest Asia, where M is virtually
absent.1
Many studies in humans and other species have indi-
cated the importance of nonneutral mtDNA variation.
For instance, by comparing the sequences of the gene
MT-ND3 among 61 humans, five chimpanzees, and one
gorilla, Nachman et al.6 observed that the ratio of replace-
ment to silent nucleotide substitutions was higher within
humans and within chimpanzees than in comparisons
between the two species, contrary to neutral expectations.
This result was later confirmed in 17 out of 25 studied
animal species7 and attributed to a substantial number of
mildly deleterious amino acid mutations that contribute
to heterozygosity but rarely become fixed in the popula-
tion. Since then, many other authors have published
reports on the effect of purifying selection against nonsy-
nonymous mutations in mtDNA in many other species,
such as in Ade´lie penguins8 in which recent and ancient
mtDNA samples were compared and in mice9 in which
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If selection on human mtDNA variations were to vary
across the globe, the distribution of lineages would be
influenced, thus affecting inferences on humanmigrations
and age estimates for branch divergences in the phyloge-
netic tree. An early analysis of 104 worldwide human
mtDNA complete sequences10 proposed climate as a selec-
tion force that shaped humanmtDNA variation differently
in the arctic and temperate zones, although not being
effective in tropical Africa. This claimhas been controversial
and has been refuted through phylogenetic analyses11–13
and an experimental bioenergetics approach.14 Accepting
a scenario of purifying selection acting equally throughout
the human mtDNA tree, Soares et al. have proposed
a correction to the molecular clock that includes the
modest effect of selection.15
Phylogenetic evaluations of selection in humans have
mainly been restricted to comparisons either between hap-
logroups observed in the three main geographic
regions10,12,13,16 or by comparing terminal branches to
internal branches of the tree.11,17 The haplogroupmethods
suffer from a problem ofmixing lineages with diverse times
of emergence, whereas the branch comparison method
suffers from a similar problem of combining internal
branches that can differ by almost 200,000 years in their
time of formation.1,15 In order to avoid these simplifica-
tions and use the full complexity of the human mtDNA
phylogenetic tree, the statistic r, whichmeasures the diver-
sity (the average number of sites differing between a set of
sequences and a specified common ancestor) accumulated
in each node of the tree18 can be used. The value ofIMUP), Porto 4200-465, Portugal; 2Faculdade de Medicina da Universidade
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r increases with increasing depth of a node within the tree,
corresponding to increasing age of the node. Thus, r is an
objective measure of the depth of a node within the tree
and is an indicator of the age of the mutations defining
the branch leading to that node. Converting r to time
would require assumptions about the consistency of muta-
tion rates on different branches of the phylogenetic tree,
and there is some disagreement in the literature related to
differences in mutation rates.15,19 That subjectivity can be
avoided by not transforming r into time.
Another major factor in evaluating selection is the defi-
nition of a deleterious mutation. Traditionally, ratios of
nonsynonymous and synonymous variations are
compared, but this lumps together all nonsynonymous
variations even though many substitutions of amino acids
with similar physical and chemical properties are well
tolerated (perhaps even neutral).20,21 As an estimate of
the impact of an amino acid change on the protein func-
tion, we used the recently developed MutPred score,22
which builds on the well-established SIFT method.23
This score is based upon the protein sequence, structural
features, and comparison between functional sites in
putatively neutral variations and reported pathogenic
mutations. The MutPred pathogenicity score ranges from
0 to 1. Higher pathogenicity scores correspond to a greater
likelihood that the amino acid variation might be patho-
genic.
In this work, we used the phylogenetic reconstruction
from two recent sources,2,15 one for the M and N subtrees
(based on 843 and 1154 sequences, respectively) and the
second for the L subtree excluding M and N (based on
624 sequences). We then evaluated the distribution of
MutPred pathogenicity scores for nonsynonymous substi-
tutions along the trees by using r as an objective measure
of the depth of a node. For comparison, we also calculated
the MutPred pathogenicity score for all of the 24,206
possible amino acid changes (defined as single point muta-
tions from the revised Cambridge reference sequence24) on
the 13 human mtDNA-encoded proteins.25
Material and Methods
Pathogenicity Measure
The MutPred analysis score22 was used as a proxy for the pathoge-
nicity of an amino acid variation for the 13 proteins encoded by
the mtDNA. Higher pathogenicity scores correspond to a greater
likelihood that the amino acid variation is pathogenic. The revised
Cambridge reference sequence (rCRS24) was used to define the
reference amino acid sequence of each gene. Pathogenicity scores
were calculated for all of the 24,206 possible amino acid variations
defined by a single point mutation away from the reference
sequence. The list of all possible amino acid variations from the
reference sequence was defined by using the mtDNA-GeneSyn
software.25 All observed protein variants listed in the L, M, and
N trees (described below) were included in this list, indicating
that this list of all possible variants was sufficient (i.e., two or
more nucleotide variations within a single codon were not
needed).434 The American Journal of Human Genetics 88, 433–439, April 8, 2The MutPred score is determined by a set of features reflecting
protein structure and its dynamics, the presence of functional resi-
dues, biases of amino acid sequence, and evolutionary conserva-
tion at the substitution site and in its neighborhood. The software
was trained as a random forest classification model26 to discrimi-
nate between disease-associated amino acid substitutions from
the Human Gene Mutation Database27 and putatively neutral
polymorphisms from Swiss-Prot.28 In addition to its pathogenicity
(or general) score, MutPred also outputs p values for various
hypotheses (property scores) regarding the molecular basis of
disease (e.g., loss of structure, gain of a phosphorylation site,
etc.). In this work, only the pathogenicity score was analyzed.
The MutPred scoring software was trained on a set of 65,657 re-
ported variants on 10,150 proteins.22 The vast majority of this
training set consisted of nuclear-encoded genes. Ninety-six of
the variants in the training set were mtDNA population variants,
and 57 of these variants were involved in this phylogenic analysis
(0.09% of the training set). No mtDNA variants were included in
the pathogenic training set.Human mtDNA Phylogeny
Two recent sources were used to define the three basic subtrees for
the human mtDNA phylogeny. Soares et al.15 was used for the M
andN subtrees, which contain 843 and 1154 samples, respectively.
Because the level of detail in the L subtree excludingM and N, rep-
resented as L(xM,N), in Soares et al.15 was much lower (199
samples) than the one in Behar et al.2, the latter was used as the
source for the L(xM,N) subtree in this analysis (624 samples).
The nonsynonymous variations within the protein genes were
identified for each branch of the three trees. For each node on
the M, N, and L trees, we calculated the r value,18 that is, the
average number of sites differing between a set of sequences and
a specified common ancestor. Because variations are associated
with branches and r values are properties of nodes, a choice of r
value (upper or lower node on the branch) must be made. The r
of the node at the distal (lower) end of the branch was used in
this analysis. This value provides a lower bound on the age of
a mutation. We did not attempt to convert the r values to actual
ages to avoid making unnecessary assumptions about the muta-
tion rate. Variations that occurred independently on separate
branches of the trees were necessarily included in the analysis
multiple times, once for each branch on which they indepen-
dently arose. The complete data set is given in Table S1.Reported Pathogenic mtDNAVariations
All reported pathogenic variations in mtDNA in the Online
Mendelian Inheritance in Man (OMIM) database as of December
2010 were collected. The reported pathogenic variations resulting
in a single amino acid change were analyzed (Table S2). Insertion
and deletion variants and premature stop codons were not
analyzed because the pathogenicity score used here only applies
to single amino acid variations. To avoid bias, we analyzed all of
these reported pathogenic variations without attempting to eval-
uate the evidence for pathogenicity in each case or the magnitude
of the pathogenic effect. Such evaluations were judged to be too
subjective.Statistics and Exponential Fit
The p values for all comparisons of mean values were calculated in
Excel by using two-tailed t tests assuming unequal variances. A
selection function for the amino acid variants was calculated by011
Figure 1. Average Values of the Statistic r for All Nonsynony-
mous Variations on Every Node in the Three Human mtDNA
Subtrees, Macrohaplogroups L, M, and N
The variations are broken down by the pathogenicity score
(ranging from 0 to 1) of the variation, averaged over bins of size
0.1. Values below 0.1 and above 0.9 are not averaged because
of the small number of data points in those ranges (n¼3withpath-
ogenicity score < 0.1 and n¼ 7 with pathogenicity score > 0.9).
The values plotted are mean 5 2 standard errors of the mean
(SEM).dividing the distribution of pathogenicity scores for all observed
protein variants by the distribution of scores for all possible varia-
tions. The nonlinear curve fit of the selection function to the path-
ogenicity score was done in Origin 7. The fit had R2 ¼ 0.96 with a
p value< 0.0001. The fit had the exponential form (145 2)3 exp
(S/(0.265 0.04)), where S is the pathogenicity score.
Figure 2. Statistics of the Distribution of the Pathogenicity
Scores in the Human Phylogenetics Trees
(A) A comparison of the average r values for amino acid variants in
the L, M, and N trees for pathogenicity scores lower and higher
than 0.7.
(B) Average pathogenicity scores for the variants that occur only
once in the tree, two to nine times, and ten or more times.
In both panels the values plotted are mean5 2 SEM. The p values
are for a two-tailed t test comparison of the average values.Results
The pathogenicity scores for all nonsynonymous amino
acid variations occurring in the three human mtDNA sub-
trees (a total of 938 amino acid variants distributed on
2227 branches of the phylogenetic tree) displayed a trend
of decreasing r value as the pathogenicity score increases
and a rapid drop in average r value for pathogenicity scores
greater than 0.6 to 0.7 (Figure 1 and Figure S1). High path-
ogenicity scores are absent from the older nodes (higher r
values) in the tree (Figures S1 and S2). Based on this
pattern, we separated the amino acid variants into a high
pathogenicity score group (R0.7) and a low pathogenicity
score group (<0.7). For the L, M, and N trees, the high
pathogenicity score group occurred preferentially on
younger branches of the trees, indicated by low average r
values (Figure 2A), consistent with selection against these
variants. Compared across all three trees there is no signif-
icant difference in the average r value in the variants with
high pathogenicity scores. The much deeper time scale of
the L tree can be seen in the much higher r values for
the low pathogenicity score variants in that tree.The AmIt is fairly common that an mtDNA variation occurs on
multiple independent branches of the phylogenetic tree.
Thesemultiple occurrences indicatemultiple and indepen-
dent mutation events forming the same variant. A reason-
able hypothesis is that those variants that have formed
multiple times in human evolution, and that have
survived purifying selection multiple times should have
lower pathogenicity scores. To test this hypothesis, we
grouped the variants into those that occurred (over the L,
M, and N trees combined) only once (n ¼ 528 variants),
those that occurred two to nine times (n ¼ 388), and those
that occurred ten or more times (n¼ 22) and calculated the
average pathogenicity score in each group. These average
pathogenicity scores show a statistically very significanterican Journal of Human Genetics 88, 433–439, April 8, 2011 435
Figure 3. Assessing Selection as a Function of the Pathogenicity
Score
(A) Probability distributions of the observed amino acid variation
pathogenicity scores for each of the three humanmtDNA subtrees
and the OMIM list of pathogenic mtDNA variants compared
against the probability distribution of all possible variations.
(B) The selection function for the amino acid variants defined by
dividing the observed distributions of pathogenicity scores by
the distribution of scores for all possible variations. The exponen-
tial fit is to the data with pathogenicity scores from 0.2 to 0.9
(R2 ¼ 0.96).decrease as the number of occurrences of the variation in
the human phylogenetic tree increases (Figure 2B), indi-
cating that a lower predicted pathogenicity is needed for
a variation to survive multiple times within the tree. The
observation that some mtDNA mutations have reoccurred
many time independently in recent human evolution is
often attributed to higher mutation rates for these partic-
ular variations.15,29 The result in Figure 2B indicates that
the number of times that a variation occurs in the tree is
a complicated combination of both mutation rates that
might vary with position and purifying selection that
varies with the pathogenicity score of the variation.
The observed nonsynonymous variations in the human
mtDNA phylogenetic trees are only a small fraction of all
the possible amino acids changes that could occur through
a single nucleotide change. We compared the probability
distributions of the pathogenicity score for the amino
acid variants in each tree to the distribution of the patho-
genicity scores for all possible variants (Figure 3A). The set
of all possible variations is strongly skewed toward higher
pathogenicity scores, indicating that most variants are
deleterious. The three human mtDNA trees all have
much lower average pathogenicity scores than the set of
all possible variations (p < 10100). Surprisingly, the distri-
bution of pathogenicity scores in each of the three trees is
nearly identical, and the average scores are not signifi-
cantly different (L versus M, p ¼ 0.20; L versus N, p ¼
0.97; M versus N, p ¼ 0.16).
As noted above, several mtDNA variants have indepen-
dently arisen multiple times throughout the human
phylogenetic tree. We then checked whether the agree-
ment of the distribution of pathogenicity scores in the
three trees could be due to the same amino acid changes
occurring on the three trees. To test this, we analyzed
only the subset of variants that were unique to each tree
(187 unique variants for L, 221 for M, and 327 for N).
Even just considering the unique nonsynonymous vari-
ants from each of the trees, the plots were remarkably
similar (Figure S3) and clearly different than the distribu-
tion of all possible variants. The mean values for the path-
ogenicity scores of the variants specific to each tree were
not significantly different (L versus M, p ¼ 0.8; L versus
N, p ¼ 0.8; M versus N, p ¼ 0.9).
A possible explanation for the difference in probability
distribution between the observed variants and the list of
all possible variations is that the list of all possible variants
consists mainly of amino acid variants caused by transver-
sions, whereas the observed variants consist overwhelm-
ingly of transitions. If there was a strong difference in
the pathogenicity scores for transitions compared to trans-
versions, then this could be the cause for the difference
between the distributions of the observed variants and all
possible variants. To test this, we split the list of all possible
variants into those variants arising from transitions and
those arising from transversions (Figure S4). The distribu-
tions of the pathogenicity scores for transitions and trans-
versions are very similar, and the set of all possible transi-436 The American Journal of Human Genetics 88, 433–439, April 8, 2tions is still significantly different from the observed
variants (p < 10100), so this explanation can be confi-
dently rejected.
As a counterpoint to the population level variants, it is
instructive to consider the properties of the identified
pathogenic mutations in the mitochondrially encoded
proteins. For an authoritative source for identified patho-
genic mutations in the 13 mtDNA-encoded proteins, we
used the OMIM database, which currently lists 75 patho-
genic variants in these proteins involving a single amino
acid change (Table S2). To avoid bias in the definition of
this list, we included all such variants listed in OMIM
without attempting to assess the severity of the pathology
or the strength of the evidence for pathogenicity. The
distribution of the pathogenicity scores for these reported
pathogenic mutations (Figure 3A) is remarkably close to
the distribution for all possible variants. The mean patho-
genicity score for the OMIM pathogenic variants is only011
Figure 4. Comparing Old and Recent Variants
Probability distributions of the pathogenicity scores for recently
formed protein variants (defined as those on branches connecting
nodes with r ¼ 0 and r% 2) and old variants (r R 20).slightly higher than that of all possible variants (mean ¼
0.685 0.03 for OMIM variants, 0.6455 0.002 for all vari-
ants), and the difference between these means does not
quite reach statistical significance (p ¼ 0.06). This agree-
ment between the probability distributions indicates that
the pathogenic variants approximate a random sample
from all possible variations, thus indicating that purifying
selection has not yet acted strongly upon these variants.
We can use the evolution of human mtDNA-encoded
proteins as a natural experiment to quantitatively measure
the effect of selection on variations in these proteins. We
defined a selection function for the amino acid variants
by dividing the distribution of pathogenicity scores for
all observed protein variants by the distribution of scores
for all possible variations (Figure 3B). This selection func-
tion for all three trees is consistent with a remarkably
simple exponential decay (R2 ¼ 0.96, p < 0.0001) of the
form
Pobserved=PAllpossible ¼ ð1452ÞeS=ð0:2650:04Þ
where P is the probability distribution of the pathogenicity
scores and S is the pathogenicity score. Curiously, the
measured selection function values for the variants with
very high pathogenicity score (>0.9) lie quite a bit above
the exponential fit in all three trees (Figure 3B). At this
time we cannot say whether this is due just to noise or
sequencing errors introducing unreal variations or
whether there is something different about the purifying
selection that has acted on those variants with extremely
high pathogenicity score. The consistency of the selection
function values from the L, M, and N trees indicates that
there is no significant difference in the selection that has
occurred in the evolution of populations from these three
geographical groups. This definition of the selection func-
tion gives a biologically-based calibration of the pathoge-
nicity scores by using human evolution as the determinant
of that scale.
The progress over time of the purifying selection on
human mtDNA can be seen by comparing the pathoge-
nicity scores of recently acquired mutations to the oldest
variations (Figure 4). We defined recently acquired variants
as those on the branches connecting nodes with r values
between 0 (the leaves of the trees) and 2. For comparison,
the old variations were defined as those on branches above
nodes with r values of 20 or higher. There were 182 recent
variants and 23 old variants. As should be expected, the
vast majority of the old variants were from the L tree
(n ¼ 18) representing the sub-Saharan Africa population,
but there were also four variants from the M tree and one
from the N tree. The pathogenicity scores for the oldest
variants are significantly shifted (p ¼ 0.0009 from a two-
tailed t test for difference in the means; p ¼ 0.0016 from
a nondirectional Mann-Whitney test) to lower values
compared to the most recently acquired variants (the
mean pathogenicity score for the new variants was 0.51,
and for the old variants was 0.40). By comparing theThe Amshapes of the distributions, it is clear that this difference
has developed through the loss of the variants with
a higher pathogenicity score.Discussion
mtDNA has a special feature that makes it a useful genomic
tool for the difficult issue of evaluating selection. The
maternal inheritance of mtDNA avoids the shuffling by
recombination of alleles inherited from both parents that
occurs in nuclear DNA genes. That lack of recombination
from the two parents means a single clear phylogeny can
be constructed for these 13 mtDNA-encoded genes, ex-
tending back to the most recent maternal ancestor,
roughly 200,000 years ago. That phylogeny is now well es-
tablished and has been described in great detail, allowing
us to determine the time-order of the formation of all of
these variations in these genes. The same analysis would
be far more difficult, perhaps impracticably so, for nuclear
genes, including the ones that code for proteins of the
oxidative respiratory chain. These nuclear-encoded genes
for mitochondrial proteins are of particular interest
because they must coadapt with mitochondrial genes
because proteins coded by both genomes interact to form
the oxidative phosphorylation protein complexes.30,31
The equivalent distribution of pathogenicity scores
for the L, M, and N trees indicates that the purifying selec-
tive forces producing these distributions have been equal
on each of the trees despite their different geographic
distributions and thus different climates affecting these
populations. This implies that the primary selective force
acting on the mtDNA-encoded proteins does not involve
adaptive evolution for temperature regulation or any other
environmental factor that might differ between the sub-
Saharan African populations and the rest of the globalerican Journal of Human Genetics 88, 433–439, April 8, 2011 437
population. However, this analysis involves the statistics of
the probability distributions of the complete set of varia-
tions of the 13 mtDNA-encoded proteins, so we can only
draw conclusions about the general forces of selection
acting across the full set of protein variations. By necessity,
this analysis might not detect selection effects focused on
a very small set of variations.
Other than varying environmental effects, what other
factors might have affected the global distribution of
mtDNA variants? The effective population size could be
an important variable. The survival of mutations within
any population, or subpopulation, is determined by the
balance of selection (either positive or negative) and
random drift. The weight of random drift in this balance
is strongly affected by the effective population size32 and
smaller subpopulations are more likely to retain delete-
rious mutations through random drift. Considering the
large bottleneck that must have occurred in the migration
of the European and Asiatic ancestral population out of
Africa, the effective population sizes must have varied
greatly between the African and non-African branches of
humanity. This raises the possibility that random drift
alone might have increased the survival of deleterious
mutations in the M and N subtrees. The fact that we do
not see any indication of such a difference in this data
(Figure 3) indicates that the purifying selection effects on
mtDNA variation were strong enough to outweigh the
varying effects of random drift between the L, M, and N
subtrees.
The quantitative approach used here combining phylo-
genetics and pathogenicity scoring is a powerful method
for evaluating and quantifying the effect of selection on
protein variants. By using these methods, we can use the
evolution of humans over the past 200,000 years to cali-
brate the force of selection on these proteins. In
Figure 3B we showed that the probability distribution for
the observed mtDNA-encoded protein variants divided
by the probability distribution for the set of all possible
variations on these proteins had a surprisingly simple
and clear exponential function. We propose that the rela-
tive effect of selection on two different amino acid varia-
tions with pathogenicity scores S1 and S2 can be assessed
by a ratio of this exponential function for the two S values.
For example, based on this exponential selection function
a variation with a pathogenicity score of 0.8 is more than
twice as bad as a variation with score 0.6 (calculate by
exp((0.8-0.6)/0.26) ¼ 2.2), meaning that mtDNA-encoded
protein variations with pathogenicity score of 0.8 have
experienced twice as much purifying selection in recent
human evolution compared to variations with pathoge-
nicity score of 0.6.
In Table S3, we provide the list of all possible amino acid
variations that can be reached by a single nucleotide shift
from the human mtDNA reference sequence and include
pathogenicity scores and predicted selection strengths for
each variant. These data could be of use in evaluating the
case for pathogenicity of novel variants in the mtDNA-438 The American Journal of Human Genetics 88, 433–439, April 8, 2encoded proteins of patients with mitochondrial diseases
of unknown origin or in evaluating the possible functional
changes of somatic mtDNA mutations acquired through
the aging process or in cancer cells.Supplemental Data
Supplemental Data include four figures and three tables and can
be found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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